Dead or alive? New confirmatory test using quantitative analysis of computed tomographic angiography.

J Trauma Acute Care Surg

From the Departments of Surgery (L.P.S.-K., W.J.B., F.E.D.), and Radiology (D.A.P., P.M.B.), and The Curtis and Elizabeth Anderson Cancer Institute (E.J.C.), Memorial University Medical Center; Department of Surgery (W.J.B., F.E.D.), Mercer University School of Medicine; and Neurologic Institute of Savannah & Center for Spine (J.U.H.), Savannah; and Department of Surgery (C.M.M.), Liberty Regional Medical Center, Hinesville, Georgia.

Published: December 2015

AI Article Synopsis

  • The study compares the effectiveness of Computed Tomographic Angiography (CTA) and Nuclear Medicine Perfusion Test (NMPT) in diagnosing brain death (BD), involving 60 clinically determined BD patients and a control group of 20.
  • Results showed that 88% of BD patients had no cerebral blood flow (CBF) on NMPT, whereas only 50% showed the same on CTA, leading to the identification of three distinct groups based on blood flow outcomes from both tests.
  • The researchers recommend a threshold of Hounsfield units less than 80 in specific arteries on CTA to confirm BD, achieving a high sensitivity of 97% and specificity of 100% in identifying a lack of

Article Abstract

Background: When clinical examination is not reliable for brain death (BD) diagnosis, the preferred confirmatory test at our institution is nuclear medicine perfusion test (NMPT). Computed tomographic angiography (CTA) has been described as an alternative for BD confirmation. This study was designed to quantitatively analyze CTA, assess its accuracy compared with NMPT, and define set parameters for BD confirmation.

Methods: This is a prospective clinical study, from 2007 to 2014, evaluating a consecutive series of clinically BD patients (n = 60) and randomly selected control group with normal CTA findings (n = 20). NMPT, used as the reference standard, was performed on all study patients followed immediately by CTA. Assessment of NMPT and quantitative CTA Hounsfield units of the horizontal segment of middle cerebral artery (M1), precommunicating segment of anterior cerebral artery (A1), and basilar artery (BA) was performed.

Results: In the study cohort, 88% demonstrated absence of cerebral blood flow (CBF) on NMPT; however, only 50% demonstrated absence on CTA. Together, 50% had no CBF on NMPT and CTA (Group 1), 38% had no CBF on NMPT but persistent CBF on CTA (Group 2), 12% had persistent CBF on both NMPT and CTA (Group 3). Analysis of variance demonstrated that all groups varied significantly for M1, A1, and BA (p < 0.001). We were able to establish criteria that differentiate persistent CBF on CTA as either preserved cerebral perfusion or stasis filling.

Conclusion: We propose that a CTA Hounsfield units less than 80 in M1, A1, and BA is concordant with no CBF on NMPT, therefore indicative of a lack of physiologic cerebral perfusion, and thus allows the confirmation of BD with 97% sensitivity and 100% specificity.

Level Of Evidence: Diagnostic study, level II.

Download full-text PDF

Source
http://dx.doi.org/10.1097/TA.0000000000000831DOI Listing

Publication Analysis

Top Keywords

cbf nmpt
20
cta group
12
persistent cbf
12
cta
11
nmpt
9
confirmatory test
8
computed tomographic
8
tomographic angiography
8
cta hounsfield
8
hounsfield units
8

Similar Publications

Dead or alive? New confirmatory test using quantitative analysis of computed tomographic angiography.

J Trauma Acute Care Surg

December 2015

From the Departments of Surgery (L.P.S.-K., W.J.B., F.E.D.), and Radiology (D.A.P., P.M.B.), and The Curtis and Elizabeth Anderson Cancer Institute (E.J.C.), Memorial University Medical Center; Department of Surgery (W.J.B., F.E.D.), Mercer University School of Medicine; and Neurologic Institute of Savannah & Center for Spine (J.U.H.), Savannah; and Department of Surgery (C.M.M.), Liberty Regional Medical Center, Hinesville, Georgia.

Article Synopsis
  • The study compares the effectiveness of Computed Tomographic Angiography (CTA) and Nuclear Medicine Perfusion Test (NMPT) in diagnosing brain death (BD), involving 60 clinically determined BD patients and a control group of 20.
  • Results showed that 88% of BD patients had no cerebral blood flow (CBF) on NMPT, whereas only 50% showed the same on CTA, leading to the identification of three distinct groups based on blood flow outcomes from both tests.
  • The researchers recommend a threshold of Hounsfield units less than 80 in specific arteries on CTA to confirm BD, achieving a high sensitivity of 97% and specificity of 100% in identifying a lack of
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!